4P004 represents a first-in-class application of GLP-1 receptor agonism in the intra-articular space, specifically targeting patients with knee osteoarthritis and synovitis who have failed multiple ...

For permission requests, please contact NEJM Reprints at [email protected] Select the format you want to export the citation of this publication.

Internal derangement of the knee (IDK) describes disorders affecting the knee joint. These can include a torn meniscus, loose bodies in the knee, cartilage damage, and damaged collateral or cruciate ...

Compared with placebo, patients who received MM-II had clinically meaningful and sustained pain relief for up to 26 weeks. The Food and Drug Administration (FDA) has granted Fast Track designation to ...